SUN — Surgical Innovations Share Price
Last trade - 00:00- £4.66m
- £5.83m
- £12.01m
- 29
- 74
- 56
- 52
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.47 | ||
| Price to Tang. Book | 1.38 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.37 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.56% | ||
| Return on Equity | -6.04% | ||
| Operating Margin | -5.76% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 10.73 | 6.33 | 9.13 | 11.34 | 12.01 | 12.4 | n/a | 1.84% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Surgical Innovations Group Plc is a holding company that is involved in the design, manufacture, sale and distribution of quality medical products, primarily for use in minimally invasive surgery. In addition, the Company designs and develops medical devices for original equipment manufacturer (OEM) partners. The Company’s segments include SI Brand, OEM, and Distribution. The SI Brand segment is engaged in the research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third party medical device companies through their own label or co-branding. It also includes research, development, manufacture, and sale of minimally invasive technology products for precision engineering applications. The Distribution segment is engaged in the distribution of specialist medical products sold by Elemental Healthcare Ltd.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- September 20th, 1988
- Public Since
- July 7th, 1998
- No. of Employees
- 101
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 932,816,177
- Address
- Clayton Wood House, 6 Clayton Wood Bank, LEEDS, LS16 6QZ
- Web
- https://www.sigroupplc.com/
- Phone
- +44 1132307597
- Auditors
- Saffery Champness LLP
Latest News for SUN
Upcoming Events for SUN
Full Year 2024 Surgical Innovations Group PLC Earnings Release
Surgical Innovations Group PLC Annual Shareholders Meeting
Half Year 2025 Surgical Innovations Group PLC Earnings Release
Similar to SUN
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Angle
London Stock Exchange
Aoti
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 23:31 UTC, shares in Surgical Innovations are trading at 0.50p. This share price information is delayed by 15 minutes.
Shares in Surgical Innovations last closed at 0.50p and the price had moved by +25% over the past 365 days. In terms of relative price strength the Surgical Innovations share price has outperformed the FTSE All Share Index by +20.09% over the past year.
The overall consensus recommendation for Surgical Innovations is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreSurgical Innovations does not currently pay a dividend.
Surgical Innovations does not currently pay a dividend.
Surgical Innovations does not currently pay a dividend.
To buy shares in Surgical Innovations you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 0.50p, shares in Surgical Innovations had a market capitalisation of £4.66m.
Here are the trading details for Surgical Innovations:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: SUN
Based on an overall assessment of its quality, value and momentum Surgical Innovations is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Surgical Innovations is 1.90p. That is 280% above the last closing price of 0.50p.
Analysts covering Surgical Innovations currently have a consensus Earnings Per Share (EPS) forecast of -£0.00 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Surgical Innovations. Over the past six months, its share price has underperformed the FTSE All Share Index by -7.63%.
As of the last closing price of 0.50p, shares in Surgical Innovations were trading -15.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Surgical Innovations PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 0.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Surgical Innovations' management team is headed by:
- Nigel Rogers - NEC
- David Marsh - CEO
- Charmaine Day - CFO
- Michael McMahon - NED
- Paul Hardy - NID